REAL WORLD DATA OF THE SAFETY AND EFFICACY OF TALICABTAGENE AUTOLEUCEL (HUMANIZED CD19 CAR-T) IN RELAPSED/REFRACTORY B-ACUTE LYMPHOBLASTIC LEUKEMIA FROM INDIA.

EHA Library, Hasmukh Jain, 4160458

EFFICACY AND SAFETY OF THE THIRD-GENERATION TYROSINE KINASE INHIBITOR OLVEREMBATINIB IN COMBINATION WITH INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF ADULT PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS WITH RELAPSED DISEASE OR PERSISTENT MINIMAL RESIDUAL DISEASE BRIDGING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION: A PHASE II STUDY

EHA Library, Xiaoyu Zhang, 4160463

GENETIC CHARACTERISTICS OF BCR::ABL1-POSITIVE B-ACUTE LYMPHOBLASTIC LEUKEMIA WITH MULTILINEAGE INVOLVEMENT AND POST-HSCT SURVIVAL ANALYSIS

EHA Library, Tong Wang, 4160464

CLINICAL ANALYSIS OF SEQUENTIAL CAR-T CELL THERAPY COMBINED WITH VENETOCLAX, HYPOMETHYLATING AGENTS, AND PERSONALIZED TARGETED DRUGS IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY ACUTE B-CELL LYMPHOBLASTIC LEUKEMIA

EHA Library, Zhao defeng, 4160466

PROGNOSTIC CLASSIFICATION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: INTEGRATED ANALYSIS OF CLINICAL AND GENETIC FEATURES

EHA Library, Kana Kato, 4160467

COMBINATION OF VENETOCLAX AND DARATUMUMAB PLUS CAG REGIMEN IS AN EFFECTIVE TRANSPLANT BRIDGING REGIMEN IN ADULT T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH POSITIVE MINIMAL RESIDUAL DISEASE

EHA Library, Li-Jun Peng, 4160469

CO-OCCURRENCE OF CHILDHOOD ACUTE LEUKEMIA AND TYPE 1 DIABETES MELLITUS: A FINNISH CASE-CONTROL STUDY

EHA Library, Julia Ventelä, 4160473

TARGETING MUTANT TP53 ACUTE MYELOID LEUKEMIA THROUGH DISRUPTION OF MYC-GSPT1 AXIS

EHA Library, Michael Andreeff, 4160474

CHARACTERIZATION OF A NOVEL MOLECULAR DEPENDENCY IN HOXA9/MEIS1+ ACUTE MYELOID LEUKEMIA (AML)

EHA Library, Federica Valigi, 4160477

SINGLE-CELL DISSECTION OF SELF-DERIVED VERSUS DONOR-DERIVED T-CELL EXHAUSTION IN BONE MARROW NICHES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Chunzi Yu, 4160481

CXCR4 EXPRESSION IN AML BLASTS AND ITS IMPACT ON CXCR4 INHIBITOR EFFICACY DURING CONSOLIDATION THERAPY: RESULTS FROM THE SAL BLAST TRIAL

EHA Library, Enise Ceran, 4160482

MITOLEUK SCORE: MITOCHONDRIAL GENOME VARIANTS AS A PROGNOSTIC CLASSIFIER FOR ACUTE MYELOID LEUKEMIA COMPLEMENTARY TO EUROPEAN LEUKEMIANET CLASSIFICATION

EHA Library, Julie Mondet, 4160483

PEDIATRIC AML BLASTS PROMOTE AN IMMUNOSUPPRESSIVE M2-LIKE PHENOTYPE BY REPROGRAMMING MACROPHAGE METABOLISM.

EHA Library, Alicia Perzolli, 4160485

DEEP IMMUNOPHENOTYPING BY MASS CYTOMETRY ELUCIDATES THE PROGENITOR TRAJECTORY OF ERYTHROID-DERIVED ACUTE MYELOID LEUKEMIA

EHA Library, Inga KF Motzfeldt, 4160487

OXPHOS-DRIVEN M2-POLARIZED MACROPHAGES SUPPORT LEUKEMIC CELL GROWTH THROUGH MITOCHONDRIAL TRANSFER

EHA Library, Wendy Boschloo, 4160491

ONCOGENIC ASPP2K IN ACUTE MYELOID LEUKEMIA (AML): A POTENTIAL PREDICTIVE MARKER AND NOVEL THERAPEUTIC TARGET

EHA Library, Kerstin Kampa-Schittenhelm, 4160492

MANNOSE METABOLISM INHIBITION IS TOXIC TOWARDS ACUTE MYELOID LEUKAEMIA STEM CELLS WHILE SPARING NORMAL HAEMATOPOIETIC CELLS AT STEADY STATE.

EHA Library, Samantha Mason, 4160493

DRUG PERSISTENCE TO RESISTANCE EVOLUTION ANALYSIS IN HUMAN LEUKEMIA REVEALS DIVERSE LEUKEMIA-INITIATING CELL PHENOTYPES

EHA Library, Michael Milyavsky, 4160496

DECODING ACUTE MYELOID LEUKAEMIA: INTEGRATING FUNCTIONAL PHENOTYPES WITH GENOMICS

EHA Library, Prasad Iyer, 4160497

P16INK4A SUPPRESSION BY FLT3-ITD ENHANCES AML PROGRESSION: MECHANISTIC INSIGHTS AND THERAPEUTIC TARGETING OF EPIGENETIC REGULATORS

EHA Library, jiarui zheng, 4160498

THE TRANSCRIPTIONAL LANDSCAPE OF CLONAL AND MICROENVIRONMENT CELLS IN ACUTE MYELOID LEUKEMIA TREATED WITH HMA-VENETOCLAX AT SINGLE CELL LEVEL

EHA Library, Alfredo Marchetti, 4160506

IDENTIFICATION, EVALUATION AND IN VITRO VALIDATION OF IMMUNOGENIC NEOEPITOPES PREDICTED FROM ACUTE MYELOID LEUKEMIA (AML) BLASTS AFTER EXPOSURE TO SPLICING INHIBITOR DRUGS

EHA Library, Lady Espinosa, 4160509

SINGLE-CELL IMMUNOMETABOLISM REVEALS A NOVEL PROGNOSTIC BIOMARKER IN ACUTE MYELOID LEUKEMIA AND UNCOVERS THE METABOLIC ROLE OF EXTRACELLULAR VESICLES

EHA Library, Dorian Forte, 4160511

INTEGRATIVE SYSTEMS BIOLOGY APPROACH UTILIZING TRANSCRIPTOMIC AND MUTATIONAL PROFILES TO UNVEIL PROGNOSIS-ASSOCIATED MOLECULAR PATHWAYS IN ACUTE MYELOID LEUKEMIA

EHA Library, Xiaoxue Wang, 4160512

INTERLEUKIN-8 IMPEDES MEGAKARYOCYTES PROPLATELET FORMATION VIA CXCR1/2-P38-NF-E2 SIGNAL AXIS LEADING TO THROMBOCYTOPENIA IN ACUTE MYELOID LEUKEMIA

EHA Library, Jing-li Han, 4160513

WHOLE GENOME SEQUENCING REVEALS MULTI-DIMENSIONAL GENETIC ABERRATIONS AND CONTRIBUTES SIGNIFICANTLY TO ELN 2022 RISK STRATIFICATION IN ACUTE MYELOID LEUKEMIA

EHA Library, Guangxin Peng, 4160517

RAB37 ORCHESTRATES THE SREBP/SCD AXIS TO MODULATE LIPID METABOLISM AND DRIVE FERROPTOSIS RESISTANCE IN ACUTE MYELOID LEUKEMIA

EHA Library, Jishi Wang, 4160518

EXPLOITING TARGETED INHIBITION OF MASTL KINASE AS A NEW THERAPEUTIC TARGET FOR ACUTE MYELOID LEUKEMIA

EHA Library, Sandra M Martin-Guerrero, 4160522

RIPK3 INDUCES APOPTOSIS IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA CELLS VIA REGULATION OF MFN2-MEDIATED MITOCHONDRIAL FUSION

EHA Library, yan zhang, 4160523

ADVANCING NK CELL IMMUNOTHERAPY IN AML AND OVERCOMING CYTOKINE-DRIVEN ADAPTIVE RESISTANCE

EHA Library, Monika Sponheimer, 4160525

MOLECULAR CHARACTERISTICS OF AML DEFINED BY DIFFERENTIATION

EHA Library, Christoph Kornauth, 4160526

FROM XENOGRAFT TO PATIENT: THE IMPACT OF SURFACE MARKERS ON AML EXTRAMEDULLARY INVASION

EHA Library, Matteo Caridi, 4160527

VENETOCLAX INDUCES MITOCHONDRIAL APOPTOSIS AND AUTOPHAGY TO OVERCOME ARSENIC TRIOXIDE RESISTANCE IN ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Syed Hasan, 4160528

ANTI-LEUKEMIC ACTIVITY OF MITOTIC CHECKPOINT INHIBITOR BAL0891 AS MONOTHERAPY AND IN COMBINATION WITH TARGETED AGENTS

EHA Library, Mi Ji Choi, 4160531

CHARACTERISTICS AND PROGNOSTIC IMPACT OF IDH MUTATIONS IN A REAL-LIFE COHORT OF 217 PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Antonella Cucca, 4160532

SPHINGOSINE-1-PHOSPHATE (S1P) MODULATOR FTY720 SYNERGIZES WITH VENETOCLAX IN AML THROUGH MTOR PATHWAY SUPPRESSION, MITOCHONDRIAL DAMAGE, AND LYSOSOMAL STRESS INDUCTION

EHA Library, Katia Beider, 4160533

THZ1-INDUCED DNA DAMAGE TRIGGERS BOTH P53-DEPENDENT AND INDEPENDENT APOPTOSIS IN AML

EHA Library, Weidong Ding, 4160534

HOW AML MIGHT EXPLOIT RNA GRANULES FOR STRESS SHELTER, MORE THAN OTHER CANCERS.

EHA Library, Alessandro Pilli, 4160535

ABNORMAL DNA DAMAGE RESPONSE SUGGESTS NOVEL FINGERPRINT OF RELAPSE IN ACUTE MONOCYTIC LEUKEMIA POST TRANSPLANTATION

EHA Library, Yukun FENG, 4160538

A NEW ALGORITHM FOR HARMONIZING LARGE-SCALE RNA-SEQ INTEGRATION IN AML: ENABLING PLATFORM FOR DEEP ANALYSIS AND DISCOVERY

EHA Library, Matteo Caridi, 4160539

PAEONIFLORIN TARGETING M6A RNA METHYLATION IMPROVES BNIP3 ASSOCIATE MITOPHAGY IN DOXORUBICIN-INDUCED MYOCARDIAL CARDIOTOXICITY

EHA Library, Xing Cui, 4160541

LIMS1 REGULATES ACUTE MYELOID LEUKEMIA INITIATION THROUGH CELL-ADHESION INTERACTIONS AND MIGRATION OF LEUKEMIC STEM CELLS

EHA Library, Talia Velasco-Hernandez, 4160542

PATIENTS WITH RELAPSED OR REFRACTORY (R/R) NUCLEOPHOSMIN 1-MUTATED (NPM1M) ACUTE MYELOID LEUKEMIA (AML): UPDATED RESULTS FROM THE PHASE 2 AUGMENT-101 STUDY

EHA Library, Martha L Arellano, 4160543

VALIDATION OF THE EUROPEAN LEUKEMIANET 2024 RISK STRATIFICATION IN PATIENTS WITH NEWLY-DIAGNOSED AML TREATED WITH HMA+VEN: REAL-WORLD DATA BASED ON THE STUDY ALLIANCE LEUKEMIA AML REGISTRY

EHA Library, Lydia Kretschmer, 4160544

HYPOMETHYLANTS IN MONOTHERAPY OR COMBINED WITH VENETOCLAX: REAL-LIFE EXPERIENCE IN 1964 PATIENTS REPORTED TO THE PETHEMA-GPLA REGISTRY

EHA Library, Eliana Aguiar, 4160545

PROGNOSTIC VALUE OF MOLECULAR MEASURABLE RESIDUAL DISEASE MONITORED BY DIGITAL PCR BEFORE AND AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN TP53-MUTATED AML/MDS COHORT: A TROPHY STUDY

EHA Library, Yanmin Zhao, 4160548

UPDATED RESULTS AND LONGER FOLLOW-UP FROM THE AUGMENT-101 PHASE 2 STUDY OF REVUMENIB IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) KMT2AR ACUTE LEUKEMIA

EHA Library, Ibrahim Aldoss, 4160549

PHASE II STUDY OF CLADRIBINE WITH LOW DOSE CYTARABINE AND VENETOCLAX ALTERNATING WITH AZACYTIDINE AND VENETOCLAX FOR NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Alex Bataller, 4160556

SECOND INDUCTION CYCLE BEFORE ALLOHSCT DOES NOT IMPROVE SURVIVAL IN ADVERSE-RISK AML PATIENTS IN COMPLETE REMISSION AFTER FIRST INDUCTION

EHA Library, Lukas Haaksma, 4160557

HIGH EFFICIENCY OF SALVAGE THERAPY COMBINING 7 DAYS VENETOCLAX AND G-CSF, FLUDARABINE, HIGH-DOSE CYTARABINE, AND MITOXANTRONE FOLLOWED BY ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN RELAPSED/REFRACTORY ACUTE MYELOBLASTIC LEUKEMIA

EHA Library, Ahmad Ibrahim, 4160558

PRIMARY RESULTS STIMULUS-AML1: A LARGE, INTERNATIONAL, PHASE II STUDY OF SABATOLIMAB COMBINED WITH AZACITIDINE AND VENETOCLAX AS FRONTLINE THERAPY FOR UNFIT ACUTE MYELOID LEUKEMIA (AML) PATIENTS (PTS)

EHA Library, Amer M. Zeidan, 4160559

T-ACUTE LYMPHOCYTIC LEUKEMIA: NEW PERSPECTIVES ON DIFFERENCES IN IMMUNOPHENOTYPES AND GENE PROFILES BETWEEN CHILDREN AND ADULTS

EHA Library, Siyu Liu, 4160459

DEFIBROTIDE TREATMENT OUTCOMES IN PATIENTS WITH VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) OCCURRING AFTER EXPOSURE TO INOTUZUMAB (INO) OR GEMTUZUMAB (GO)

EHA Library, Mohamad Mohty, 4160460

VENETOCLAX, TUCIDINOSTAT, PEGASPARGASE, AND DEXAMETHASONE INDUCTION REGIMEN FOR NEWLY DIAGNOSED ADULT ETP-ALL: A CHEMOTHERAPY-FREE, LOW-TOXICITY, EFFECTIVE REGIMEN

EHA Library, Jieping Lin, 4160462

MRD-BASED TARGET THERAPY FOR PH-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULT PATIENTS BY THE RALL-2016M PROTOCOL: EFFECTIVE FOR BCP-ALL, SHOWS NO EFFICACY IN T-ALL

EHA Library, Olga Aleshina Gavrilina, 4160465

REAL-WORLD OUTCOMES OF PHILADELPHIA CHROMOSOME-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS TREATED WITH A PEDIATRIC-INSPIRED PROTOCOL: A COMPARISON ACROSS TWO TIME PERIODS

EHA Library, Maria Agustina Perusini, 4160468

OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN STRATIFIED BY BODY MASS INDEX

EHA Library, Wendy Stock, 4160470

NOVEL EUROFLOW QUALITY ASSESSMENT ON B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA MINIMAL RESIDUAL DISEASE. PROGRAM DEVELOPMENT AND FOUR ROUNDS OF IMPLEMENTATION

EHA Library, Michaela Reiterová, 4160471

EPIGENETIC REGULATION OF ALDH1 BY ANTHRACYCLINES DRIVES CHEMORESISTANCE IN AML AND UNVEILS A THERAPEUTIC VULNERABILITY FOR CO-TARGETING WITH DNA METHYLATION INHIBITORS

EHA Library, Mileidys Perez, 4160475

TARGETING O-GLCNAC TRANSFERASE (OGT)-MEDIATED DRUG RESISTANCE IN INV(3)/T(3;3) AML

EHA Library, Junbum Im, 4160476

TBK1-OPTN INTERACTION PROMOTES AML PROLIFERATION AND VENETOCLAX RESISTANCE BY ACTIVATING MITOPHAGY, TARGETED BY A NOVEL INHIBITOR PEPTIDE

EHA Library, Fan Niu, 4160478

GATA2 N-TERMINAL ZINC FINGER DOMAIN MUTATIONS PROMOTE ERYTHROID CLONAL EXPANSION IN ACUTE MYELOID LEUKEMIA

EHA Library, Tianhui Liu, 4160479

MAPPING LEUKEMIC STEM CELLS IN PEDIATRIC AML: A MULTIMODAL FRAMEWORK TO PRECISION TARGETING

EHA Library, sina kanannejad, 4160480

SINGLE-CELL PROFILING IDENTIFIES LEUKEMIC STEM CELL SUBTYPES LINKED TO ATRA SENSITIVITY IN RAS MUTANT ACUTE MYELOID LEUKEMIA

EHA Library, Diego A Pereira-Martins, 4160484

MICROBIOTA-INSPIRED COMPOUNDS AS NOVEL DRUG CANDIDATES TARGETING NPM1-MUTATED ACUTE MYELOID LEUKEMIA

EHA Library, Miguel Ángel Navarro Aguadero, 4160486

SYNERGISTIC EFFECTS OF PRL2 AND TKI CO-INHIBITION IN FLT3-MUTATED AND MLL-REARRANGED ACUTE MYELOID LEUKEMIA

EHA Library, Hongxia Chen, 4160488

CD180 IS A TARGETABLE MARKER FOR SENESCENCE ASSOCIATED CHEMORESISTANT IN PAEDIATRIC KMT2A-REARRANGED ACUTE MYELOID LEUKAEMIA

EHA Library, Aya Gouma, 4160489

DISRUPTING MITOCHONDRIAL FUNCTION IN ACUTE MYELOID LEUKEMIA: PERSONALIZED APPROACH TO THERAPEUTIC STRATEGY COMBINING BCL-2 INHIBITION WITH COMPLEX I BLOCKADE

EHA Library, Natalia Baran, 4160490

JAK2 R1063H GERMLINE VARIANT IN AML: ASSOCIATION WITH ONCOGENIC IDH1/2 DRIVERS RESULTING IN COOPERATIVE LEUKEMOGENESIS AND THERAPEUTIC IMPLICATIONS

EHA Library, Katarina Hlusickova Kapralova, 4160494

HIGH THROUGHPUT DRUG SCREEN COUPLED TO PROTEO-GENOMIC DATA IDENTIFIES EPIGENETIC VULNERABILITIES IN AML SUBTYPE-SPECIFIC PATIENT GROUP

EHA Library, Shanna Hogeling, 4160495

IDENTIFICATION OF ELOVL6 AS A CAUSAL FACTOR AND POTENTIAL THERAPEUTIC TARGET FOR ACUTE MYELOID LEUKEMIA

EHA Library, Linhui Hu, 4160499

RGT-61159, A POTENT AND SELECTIVE SMALL MOLECULE MYB RNA INHIBITOR, SHOWED SIGNIFICANT ANTI-TUMOR ACTIVITY AS MONOTHERAPY OR IN COMBINATION WITH STANDARDS OF CARE IN SEVERAL LEUKEMIA DISEASE MODELS HARBORING AML MOST COMMON GENETIC LESIONS

EHA Library, Patricia Soulard, 4160500

OVERCOMING AML HETEROGENEITY THROUGH MITOCHONDRIAL ACTIVITY AND AUTOPHAGY-INDUCED ENHANCEMENT OF AML CELLS BY BONE MARROW STROMAL CELLS

EHA Library, Shuqing Wang, 4160501

TARGETING DNA REPLICATION AND THE INTRA-S-PHASE CHECKPOINT FOR TREATMENT OF TP53-MUTATED AML

EHA Library, Sean Post, 4160502

ACTIVIN A INHIBITION IMPAIRED IN VITRO AML CELL MIGRATION AND IN VIVO BONE MARROW ENGRAFTMENT IN MICE

EHA Library, Blake Moses, 4160503

DIRECT FUNCTIONAL HOXA9/DNA BINDING COMPETITORS VERSUS EPIGENETIC INHIBITORS OF HOXA9 EXPRESSION ON CELL PROLIFERATION, DEATH AND DIFFERENTIATION PROCESSES IN THE MODEL OF MLL-REARRANGED ACUTE MYELOID LEUKAEMIA

EHA Library, Marie-Helene David-Cordonnier, 4160504

COMPLEMENTARITY OF HIGH-THROUGHPUT SEQUENCING AND FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE IN AML: A REAL LIFE STUDY FROM THE HAUTS-DE-FRANCE OBSERVATORY

EHA Library, Augustin Boudry, 4160505

TARGETING METABOLIC ALTERATIONS IN PML::RARα+ MYELOID CELLS TO OVERCOME RESISTANCE AND RELAPSE IN ACUTE PROMYELOCYTIC LEUKEMIA.

EHA Library, Nelida I. Noguera, 4160507

GLUCOSE METABOLIC CHANGES DRIVE DISEASE PROGRESSION AND RELAPSE IN RUNX1::ETO ACUTE MYELOID LEUKEMIA

EHA Library, Nuria Tubio Santamaria, 4160508

HPK1 INHIBITOR BGB-15025 INDUCES APOPTOSIS IN AML CELLS THROUGH CELL CYCLE PATHWAY AND MAPK/ERK SIGNALING AXIS.

EHA Library, Shiyu Yang, 4160510

DEEP TARGETED SEQUENCING TO MONITOR MEASURABLE RESIDUAL DISEASE AND CHIMERISM IN MIELOID MALIGANCIES AFTER ALLOGENIC STEM CELL TRANSPLANT

EHA Library, Irene Zamanillo, 4160514

SELECTIVE THERAPEUTIC TARGETING ON MNX1-DRIVEN PROGRAMS IN INFANT AML

EHA Library, Ylenia Cicirò, 4160515

AVPR2-DRIVEN NEUROHYPOPHYSEAL DYSFUNCTION IN ADVERSE-RISK CYTOGENETIC AML: MECHANISTIC INSIGHTS AND SURVIVAL IMPLICATIONS

EHA Library, Diyaer Abuduaini, 4160516

GUICAOBAIDU DECOCTION ALLEVIATES DOXORUBICIN-INDUCED MYOCARDIAL CARDIOTOXICITY VIA AMELIORATION OF TRDMT1/BNIP3 MEDIATED MITOPHAGY IN MICE

EHA Library, Xing Cui, 4160519

(LEUKEMIA-SPECIFC) B-CELLS IN AML PATIENTS CAN BE INDUCED BY IMMUNE MODULATORY THERAPY (KIT M: GM-CSF AND PGE-1) AND CONTRIBUTE TO IMPROVE ANTILEUKEMIC RESPONSE

EHA Library, Helga Schmetzer, 4160520

TRANSCRIPTOMIC AND CELLULAR DECONVOLUTION ANALYSIS REVEALS DISTINCT PROFILES ASSOCIATED WITH CYTARABINE RESISTANCE IN ACUTE MYELOID LEUKEMIA

EHA Library, Alba Mora, 4160521

STUDY ON THE SYNTHETIC LETHAL MECHANISM OF SELECTIVE KILLING OF ALDH2 DEFICIENT ACUTE MYELOID LEUKEMIA CELLS BY INHIBITING BRIP1

EHA Library, Jishi Wang, 4160524

DELETERIOUS ROLE OF BYSTANDER CD8 T CELLS PRODUCING GRANZYME K IN ACUTE MYELOID LEUKEMIA PROGRESSION

EHA Library, Yannick Simoni, 4160529

PROGNOSTIC IMPACT OF FLT3-ITD LENGTH AND CLONAL PERSISTENCE IN MYELOID NEOPLASMS

EHA Library, Suresh Balasubramanian, 4160530

ACUTE MYELOID LEUKEMIA WITH 7Q DELETION: INCIDENCE, PROGNOSTIC, AND IMPACT ON RESPONSE TO BORTEZOMIB IN COMBINATION WITH AZACITIDINE OF EZH2 ALTERATIONS.

EHA Library, Iván Martín, 4160536

EXPLORATION OF MUTATIONAL PATTERNS AND THEIR IMPACT ON THE IMMUNE MICROENVIRONMENT IN ACUTE MYELOID LEUKEMIA THROUGH IN SILICO ANALYSES

EHA Library, Allana Carvalho, 4160537

REGULATORY T CELL-PREDOMINANT TUMOR MICROENVIRONMENT (TME) PREDICTS POOR OUTCOMES IN BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN).

EHA Library, Claudia Tobar Cabrera, 4160540

RISK STRATIFICATION OF NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX IN COMBINATION WITH INTENSIVE CHEMOTHERAPY

EHA Library, Wei-Ying Jen, 4160546

A PHASE IB/2 TRIAL OF AN ALL-ORAL „TRIPLET” REGIMEN FOR IDH-MUTATED MYELOID MALIGNANCIES: DECITABINE/CEDAZURIDINE AND VENETOCLAX IN COMBINATION WITH IVOSIDENIB/ENASIDENIB

EHA Library, Jennifer Marvin-Peek, 4160547

CLINICAL FEATURES, TREATMENT PATTERNS AND OUTCOMES IN 405 ADULT PATIENTS WITH MIXED PHENOTYPE ACUTE LEUKEMIA: A STUDY FROM THE PETHEMA AND PALG GROUPS

EHA Library, Marta Sobas, 4160550

IS MEASURABLE RESIDUAL DISEASE (MRD) ASSESSMENT BY MULTIPARAMETER FLOW CYTOMETRY (MFC) A VALID EARLY ENDPOINT OF TREATMENT EFFICACY IN ACUTE MYELOID LEUKEMIA (AML): A PETHEMA STUDY IN 2,819 PATIENTS

EHA Library, Bruno Paiva, 4160551

VENETOCLAX PLUS HIGH-DOSE CYTARABINE AND MITOXANTRONE (HAM-VEN) IN RELAPSED/REFRACTORY AML: A REAL-WORLD ANALYSIS FROM SAL AND AMLCG STUDY CENTERS

EHA Library, Andrew Berdel, 4160552

UNVEILING DISTINCT MOLECULAR AND PROGNOSTIC FEATURES: AN RNA-BASED PROGNOSTIC MODEL FOR INFANT ACUTE MYELOID LEUKEMIA

EHA Library, YU TAO, 4160553

RESULTS FROM A CLINICAL STUDY OF THE ALL-ORAL REGIMEN OF CC-486 (ORAL AZACITIDINE) AND VENETOCLAX FOR NEWLY DIAGNOSED AND RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA

EHA Library, Maria Amaya, 4160554

THE PROGNOSTIC IMPACT OF TRISOMY 8 IN ACUTE MYELOID LEUKEMIA

EHA Library, Daniel Tuyet Kristensen, 4160555